Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
Mathieu BastardMaryline BonnetPhilipp du CrosMédecins Sans Frontières, London, United KingdomAtadjan KhamraevTashkent Pediatric Medical Institute, Tashkent, UzbekistanԱրմեն ՀայրապետյանNational Tuberculosis Control Office, Yerevan, ArmeniaKamene KimenyeProgrammatic Management of Drug-Resistant Tuberculosis, Nairobi, KenyaShazina KhurkhumalNational Tuberculosis Program, Sukhumi, AbkhaziaThemba DlaminiMinistry of Health-TB National Control Program, Mbanane, SwazilandAlex TelnovMédecins Sans Frontières, Geneva, SwitzerlandElisabeth Sánchez-PadillaCathy HewisonMédecins Sans Frontières, Paris, FranceFrancis VaraineMédecins Sans Frontières, Paris, France
ABI
Аннотация
Аннотация мавжуд эмас.
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос2 та фойдаланилган манба